The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

A new study from the Kennedy Krieger Institute is calling attention to an emerging mental health crisis among children with ...

As public health systems strain and families like Jennifer’s wait for solutions, scientists at Johns Hopkins are working ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

Long COVID—clinically known as post-acute sequelae of SARS-CoV-2 infection (PASC)—is a life-altering condition that affects more than 400 million people worldwide. Symptoms can persist for months or ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...